TG Therapeutics
TGTX
TGTX
192 hedge funds and large institutions have $1.91B invested in TG Therapeutics in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 64 increasing their positions, 64 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less funds holding
Funds holding: 221 → 192 (-29)
41% less capital invested
Capital invested by funds: $3.21B → $1.91B (-$1.3B)
46% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 56
Holders
192
Holding in Top 10
2
Calls
$61M
Puts
$55.3M
Top Buyers
| 1 | +$52M | |
| 2 | +$50.8M | |
| 3 | +$29M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.6M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$12M |
Top Sellers
| 1 | -$50.7M | |
| 2 | -$41.8M | |
| 3 | -$35.9M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$31.3M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$21.3M |